When to worry about ALT levels?

ALT levels above 40 U/L for men or 35 U/L for women may indicate liver damage, but context matters—temporary elevations from exercise or medications are common. Persistent elevations above 2-3 times normal, especially with symptoms like fatigue or jaundice, warrant medical evaluation.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding ALT and Its Role in Your Body

Alanine aminotransferase (ALT) is an enzyme found primarily in your liver cells, where it plays a crucial role in converting proteins into energy. When liver cells are damaged or inflamed, ALT leaks into your bloodstream, making it one of the most sensitive markers for liver health. While small amounts of ALT in your blood are normal, elevated levels often serve as an early warning sign that your liver needs attention.

ALT testing has become a cornerstone of routine health screenings because it can detect liver problems before symptoms appear. Unlike many health conditions that announce themselves with obvious symptoms, liver damage often progresses silently. By the time you feel unwell, significant damage may have already occurred. This makes understanding your ALT levels crucial for preventive health care.

Normal vs. Concerning ALT Levels

Normal ALT levels typically range from 7-40 U/L for men and 7-35 U/L for women, though these ranges can vary slightly between laboratories. However, recent research suggests that even levels within the 'normal' range might indicate early liver stress. Some experts now recommend optimal ALT levels below 30 U/L for men and 25 U/L for women, particularly for those focused on longevity and preventive health.

ALT Level Categories and Clinical Significance

ALT levels should always be interpreted in context with symptoms, other liver tests, and individual risk factors.
ALT LevelCategoryClinical SignificanceRecommended Action
< 30 U/L (M) / < 25 U/L (F)< 30 U/L (M) / < 25 U/L (F)OptimalIdeal for longevity and healthMaintain healthy lifestyle
30-40 U/L (M) / 25-35 U/L (F)30-40 U/L (M) / 25-35 U/L (F)NormalAcceptable but not optimalConsider lifestyle optimization
41-120 U/L41-120 U/LMildly ElevatedPossible early liver stressLifestyle changes, retest in 3-6 months
121-400 U/L121-400 U/LModerately ElevatedLikely liver diseaseMedical evaluation needed
> 400 U/L> 400 U/LSeverely ElevatedAcute liver injuryImmediate medical attention

ALT levels should always be interpreted in context with symptoms, other liver tests, and individual risk factors.

Understanding different elevation levels helps determine urgency and appropriate action:

Factors That Influence ALT Levels

Several factors can cause temporary ALT elevations that don't necessarily indicate serious liver disease. Intense exercise, particularly strength training, can raise ALT levels for 24-72 hours as muscle tissue releases the enzyme. Certain medications, including common pain relievers like acetaminophen and some cholesterol-lowering statins, can also elevate ALT. Even a single night of heavy drinking or a particularly fatty meal can cause a temporary spike.

Body weight significantly impacts ALT levels. People with obesity often have chronically elevated ALT due to non-alcoholic fatty liver disease (NAFLD), which affects up to 30% of adults in developed countries. Age and gender also play roles, with men typically having slightly higher levels than women, and ALT generally decreasing with age after 60.

Common Causes of Elevated ALT

Non-Alcoholic Fatty Liver Disease (NAFLD)

NAFLD has become the most common cause of elevated ALT in developed countries, affecting approximately 25% of the global population. This condition occurs when excess fat accumulates in liver cells, not due to alcohol consumption but rather from metabolic factors. Risk factors include obesity, insulin resistance, type 2 diabetes, and metabolic syndrome. ALT levels in NAFLD typically range from 1.5 to 3 times the upper normal limit.

Viral Hepatitis

Hepatitis B and C remain significant causes of elevated ALT worldwide. These viral infections cause ongoing liver inflammation that can lead to cirrhosis and liver cancer if left untreated. ALT levels in acute hepatitis can exceed 1000 U/L, while chronic hepatitis typically causes more modest elevations of 2-10 times normal. Early detection through ALT monitoring is crucial, as many people with viral hepatitis have no symptoms for years.

Medications and Supplements

Numerous medications can elevate ALT levels, either through direct liver toxicity or as an idiosyncratic reaction. Common culprits include:

  • Acetaminophen (especially at high doses or with alcohol)
  • Statins for cholesterol management
  • Certain antibiotics like amoxicillin-clavulanate
  • Anti-seizure medications
  • Some herbal supplements, particularly those containing green tea extract or kava

If you're taking any medications or supplements and notice elevated ALT levels, discussing alternatives with your healthcare provider is essential. Regular monitoring through comprehensive metabolic panels can help catch medication-related liver issues early.

Symptoms That May Accompany High ALT

While elevated ALT itself doesn't cause symptoms, the underlying liver conditions responsible for the elevation often do. Early liver disease frequently presents with subtle, non-specific symptoms that are easy to dismiss. Fatigue is often the first and most common complaint, described as a persistent tiredness that doesn't improve with rest. Many people also experience mild abdominal discomfort, particularly in the upper right quadrant where the liver is located.

As liver dysfunction progresses, more specific symptoms may develop:

  • Jaundice (yellowing of skin and eyes)
  • Dark urine and pale stools
  • Unexplained weight loss or gain
  • Swelling in the legs and abdomen
  • Easy bruising or bleeding
  • Confusion or difficulty concentrating (hepatic encephalopathy)
  • Spider-like blood vessels on the skin

The presence of any of these symptoms alongside elevated ALT levels warrants immediate medical evaluation. However, waiting for symptoms to appear isn't advisable, as significant liver damage can occur before symptoms manifest.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

When to Seek Medical Attention

Determining when elevated ALT levels require medical intervention depends on several factors. Any ALT level above 3 times the upper normal limit (>120 U/L for men, >105 U/L for women) deserves prompt medical evaluation, even without symptoms. Similarly, persistently elevated levels above 2 times normal for more than 6 months indicate chronic liver disease requiring investigation.

Immediate medical attention is necessary if elevated ALT accompanies:

  • Severe abdominal pain
  • Persistent vomiting
  • Confusion or altered mental state
  • Yellowing of skin or eyes
  • Severe fatigue affecting daily activities
  • Signs of bleeding or easy bruising

Even modest ALT elevations (1.5-2 times normal) merit discussion with your healthcare provider if they persist or if you have risk factors like obesity, diabetes, or a family history of liver disease. Early intervention can prevent progression to more serious conditions.

Testing and Monitoring Your ALT Levels

ALT testing is typically performed as part of a comprehensive metabolic panel (CMP) or liver function test panel. These blood tests require minimal preparation—usually just an 8-12 hour fast before the blood draw. The test itself is simple, involving a standard blood draw from a vein in your arm.

For accurate results and proper interpretation, ALT should be tested alongside other liver enzymes and markers:

  • AST (Aspartate aminotransferase) - helps determine the pattern of liver injury
  • ALP (Alkaline phosphatase) - indicates bile duct problems
  • Bilirubin - assesses liver's ability to process waste
  • Albumin and total protein - evaluate liver's synthetic function
  • GGT (Gamma-glutamyl transferase) - sensitive marker for liver disease

The frequency of ALT monitoring depends on your individual risk factors and current levels. Those with known liver conditions or taking potentially hepatotoxic medications may need monthly monitoring. For general health screening, annual testing is typically sufficient, though those with metabolic risk factors benefit from more frequent assessment. If you're interested in comprehensive metabolic health monitoring that includes ALT and other crucial liver markers, regular testing can help you track your progress and catch issues early.

Understanding Your Test Results

Interpreting ALT results requires considering the entire clinical picture. A single elevated reading doesn't necessarily indicate liver disease—it could reflect temporary factors like recent exercise or medication. Patterns over time provide more meaningful information. Rising trends, even within the normal range, may signal developing problems, while decreasing levels often indicate successful treatment or lifestyle interventions.

The ratio of AST to ALT also provides diagnostic clues. An AST:ALT ratio greater than 2:1 often suggests alcoholic liver disease, while a ratio less than 1 typically indicates NAFLD or viral hepatitis. Your healthcare provider will consider these patterns alongside your symptoms, risk factors, and other test results to determine the appropriate next steps.

Natural Ways to Lower ALT Levels

Dietary Modifications

Diet plays a crucial role in liver health and ALT levels. The Mediterranean diet, rich in vegetables, fruits, whole grains, and healthy fats, has shown particular promise in reducing ALT levels and improving liver health. Key dietary strategies include:

  • Limiting saturated fats and eliminating trans fats
  • Reducing sugar intake, especially fructose from sweetened beverages
  • Increasing fiber consumption to 25-35 grams daily
  • Incorporating omega-3 fatty acids from fish or supplements
  • Choosing complex carbohydrates over refined grains
  • Limiting alcohol consumption or abstaining completely

Coffee consumption, surprisingly, has been associated with lower ALT levels and reduced liver disease risk. Studies suggest 2-3 cups daily may provide protective benefits, though the mechanism isn't fully understood.

Exercise and Weight Management

Regular physical activity is one of the most effective interventions for lowering ALT levels, particularly in those with NAFLD. Both aerobic exercise and resistance training show benefits, with the combination being most effective. Aim for at least 150 minutes of moderate-intensity exercise weekly, though even modest increases in activity can improve liver health.

Weight loss of just 5-10% can significantly reduce ALT levels and liver fat content. However, rapid weight loss should be avoided as it can temporarily worsen liver inflammation. A gradual loss of 1-2 pounds per week through sustainable lifestyle changes provides the best outcomes for liver health.

Supplements and Natural Remedies

Several supplements have shown promise in reducing ALT levels and supporting liver health:

  • Vitamin E (800 IU daily) - particularly effective for non-diabetic NAFLD patients
  • Milk thistle (silymarin) - traditional liver support with anti-inflammatory properties
  • N-acetylcysteine - powerful antioxidant that supports liver detoxification
  • Vitamin D - deficiency is common in liver disease patients
  • Probiotics - may reduce liver inflammation through gut-liver axis

Always consult with your healthcare provider before starting supplements, as some can interact with medications or may not be appropriate for your specific condition. If you're looking to understand your complete metabolic health picture and track how lifestyle changes affect your liver markers, consider using SiPhox Health's free blood test analysis service to get personalized insights from your existing lab results.

The Bigger Picture: ALT and Overall Health

Elevated ALT levels often signal broader metabolic dysfunction beyond just liver health. Research shows strong associations between high ALT and increased risk of cardiovascular disease, type 2 diabetes, and metabolic syndrome. This connection makes sense given the liver's central role in metabolism—it processes nutrients, produces cholesterol, and regulates blood sugar.

Addressing elevated ALT levels through lifestyle modifications provides benefits that extend throughout your body. The same dietary changes that lower ALT also improve cardiovascular health, enhance insulin sensitivity, and reduce inflammation. This holistic approach to health optimization explains why comprehensive biomarker monitoring has become increasingly popular among those focused on longevity and disease prevention.

Long-term studies indicate that maintaining optimal ALT levels throughout life correlates with reduced all-cause mortality and improved healthspan. This underscores the importance of regular monitoring and proactive management, even in the absence of symptoms. By catching and addressing elevations early, you can prevent progression to more serious conditions and maintain optimal health as you age.

References

  1. Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017). ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. American Journal of Gastroenterology, 112(1), 18-35.[Link][DOI]
  2. Younossi, Z. M., et al. (2018). Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73-84.[PubMed][DOI]
  3. Ruhl, C. E., & Everhart, J. E. (2012). Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology, 55(2), 447-454.[PubMed][DOI]
  4. Chalasani, N., et al. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328-357.[PubMed][DOI]
  5. Sanyal, A. J., et al. (2010). Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. New England Journal of Medicine, 362(18), 1675-1685.[PubMed][DOI]
  6. European Association for the Study of the Liver (2021). EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis. Journal of Hepatology, 75(3), 659-689.[Link][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ALT at home?

You can test your ALT at home with SiPhox Health's Heart & Metabolic Program, which includes ALT testing along with other essential liver and metabolic markers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is the most common cause of elevated ALT?

Non-alcoholic fatty liver disease (NAFLD) is now the most common cause of elevated ALT in developed countries, affecting about 25% of adults. Other frequent causes include medications, viral hepatitis, and excessive alcohol consumption.

Can elevated ALT levels return to normal?

Yes, ALT levels often normalize with appropriate treatment of the underlying cause. Weight loss, dietary changes, exercise, and avoiding hepatotoxic substances can significantly reduce ALT levels within weeks to months.

Should I avoid exercise if my ALT is elevated?

Generally, no. While intense exercise can temporarily raise ALT levels, regular moderate exercise is beneficial for liver health and can help lower chronically elevated ALT. However, consult your doctor if your ALT is severely elevated or you have diagnosed liver disease.

What's the difference between ALT and AST?

ALT is found primarily in the liver, making it more specific for liver damage. AST is found in the liver, heart, muscles, and other organs. The ratio between these enzymes helps doctors determine the type and severity of liver problems.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details